ConductScience.org, home

Paper44375

Sulpiride in tardive dyskinesia.

Casey DE and 2 others. Psychopharmacology (Berl), 1979. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Sulpiride in tardive dyskinesia. Papers, record 44375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/44375

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sulpiride in tardive dyskinesia.
PubMed
Journal
Psychopharmacology (Berl)
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
2.83
iCite
Revised in PubMed
2026-10-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Casey DED E
2Gerlach JJ
3Simmelsgaard HH

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Dyskinesia, Drug-InducedMajor topic
SulpirideMajor topic
Aged
Antipsychotic Agents
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Parkinson Disease, Secondary
Placebos
Time Factors

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1215920Multiple receptors for dopamine.Nature1979https://conductscience.org/library/papers/215920PubMed
27373324Oxiperomide in tardive dyskinesia.J Neurol Neurosurg Psychiatry1980https://conductscience.org/library/papers/7373324PubMed
3235013Tardive dyskinesia treated with pimozide.J Neurol Sci1975https://conductscience.org/library/papers/235013PubMed
4692279A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.Life Sci1978https://conductscience.org/library/papers/692279PubMed
5103110Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.Psychopharmacology (Berl)1978https://conductscience.org/library/papers/103110PubMed
640756Tardive dyskinesia.Dan Med Bull1979https://conductscience.org/library/papers/40756PubMed
74838914Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias.J Neurol Neurosurg Psychiatry1974https://conductscience.org/library/papers/4838914PubMed
829758Benzamides and classical neuroleptics: comparison of their actions using 6 apomorphine-induced effects.Eur J Pharmacol1978https://conductscience.org/library/papers/29758PubMed
91249187Effect of sulpiride on serum prolactin levels in humans.J Clin Endocrinol Metab1976https://conductscience.org/library/papers/1249187PubMed
1021571An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels.Am J Psychiatry1977https://conductscience.org/library/papers/21571PubMed
11623338Eye blink and schizophrenia: psychosis or tardive dyskinesia?Am J Psychiatry1978https://conductscience.org/library/papers/623338PubMed
125655944Critical analysis of the disability in Parkinson's disease.Mod Treat1968https://conductscience.org/library/papers/5655944PubMed
13410053Pharmacological characterization of tardive dyskinesia.Psychopharmacology (Berl)1977https://conductscience.org/library/papers/410053PubMed
141123624Selective increase of brain dopamine synthesis by sulpiride.J Neurochem1975https://conductscience.org/library/papers/1123624PubMed
15115033Effect of sulpiride on monoaminergic mechanisms in psychotic women.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/115033PubMed
164555826Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.Arch Gen Psychiatry1972https://conductscience.org/library/papers/4555826PubMed
17638546Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias.Br Med J1978https://conductscience.org/library/papers/638546PubMed
18813995Stimulation of human prolactin secretion by sulpiride.Endocrinol Jpn1975https://conductscience.org/library/papers/813995PubMed
191095689Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.J Neurol Neurosurg Psychiatry1975https://conductscience.org/library/papers/1095689PubMed
204271860The pharmacology of extrapyramidal movement disorders.Monogr Neural Sci1973https://conductscience.org/library/papers/4271860PubMed

See all 26 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
29409162Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29409162PubMed
24729184Sulpiride versus placebo for schizophrenia.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24729184PubMed
7373324Oxiperomide in tardive dyskinesia.J Neurol Neurosurg Psychiatry1980https://conductscience.org/library/papers/7373324PubMed
7047137Management of tardive dyskinesia: current update.Drugs1982https://conductscience.org/library/papers/7047137PubMed
6542444The antidyskinetic action of dihomo-gamma-linolenic acid in the rodent.Br J Pharmacol1984https://conductscience.org/library/papers/6542444PubMed
6438683Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations.Psychopharmacology (Berl)1984https://conductscience.org/library/papers/6438683PubMed
6236286A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.J Neurol Neurosurg Psychiatry1984https://conductscience.org/library/papers/6236286PubMed
6117919Neuroleptic-induced acute dyskinesias in rhesus monkeys.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6117919PubMed
3925489Effects of tiapride in tardive dyskinesia.Psychopharmacology (Berl)1985https://conductscience.org/library/papers/3925489PubMed
2895483Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia.Psychopharmacology (Berl)1988https://conductscience.org/library/papers/2895483PubMed
2880362
Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.
Psychopharmacology (Berl)1986https://conductscience.org/library/papers/2880362PubMed
1978858Sulpiride in tardive dyskinesia.J Neurol Neurosurg Psychiatry1990https://conductscience.org/library/papers/1978858PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/44375

GET https://conductscience.org/api/papers/v1/44375/references?page=2